The HPLC assay of concentration of azithromycin from two different manufacturers in gingival crevicular fluid (GCF)
Background: Azithromycin (AZM) is used in periodontal infections. The present study compared gingival crevicular fluid concentration of azithromycin of two pharmaceutical companies through the HPLC method. Methods: Two groups (n=15) of healthy volunteers participated in this study. The first group...
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Babol University of Medical Sciences
2016-10-01
|
| Series: | Caspian Journal of Internal Medicine |
| Subjects: | |
| Online Access: | http://caspjim.com/browse.php?a_code=A-10-108-1&slc_lang=en&sid=1 |
| _version_ | 1828343559664697344 |
|---|---|
| author | Mahmoud Khosravi Samani Khashayar Dehshiri Sohrab Kazemi Mohamadreza Shiran Ali Akbar Moghadamnia |
| author_facet | Mahmoud Khosravi Samani Khashayar Dehshiri Sohrab Kazemi Mohamadreza Shiran Ali Akbar Moghadamnia |
| author_sort | Mahmoud Khosravi Samani |
| collection | DOAJ |
| description | Background: Azithromycin (AZM) is used in periodontal infections. The present study compared gingival crevicular fluid concentration of azithromycin of two pharmaceutical companies through the HPLC method.
Methods: Two groups (n=15) of healthy volunteers participated in this study. The first group received an imported azithromycin (ImAZM) tablet (250 mg, PO) and the second group received an azithromycin tablet (250 mg PO) manufactured by an Iranian pharmaceutical company (IrAZM). Intrasulcular paper points (#30) were used in inter-proximal areas of molars and canines to collect gingival crevicular fluid samples at 6, 12, 36, 84 and 156 hours after drug administration.
Results: The maximum concentration of AZM in gingival crevicular fluid was detected in each group 36 hour after administration. The concentration levels for the participants receiving ImAZM and IrAZM were 14.38±5.75 and 12.64±3.53 ng/mL, respectively. The pharmacokinetic (PK) modeling data showed half-life of AZM was 107.47 hr & 91.42 hr while the clearance was 113.02 hr &119.0 hr for the group receiving ImAZM and IrAZM, respectively. No significant differences were observed in other PK parameters, areas under the concentration time curves for the groups were almost identical.
Conclusion: According to the results, there were no significant differences between the PK parameters of ImAZM and IrAZM products. It may be concluded that different doses of AZM have relatively similar PK parameters among the healthy participants. |
| first_indexed | 2024-04-13T23:44:57Z |
| format | Article |
| id | doaj.art-facda5b7161146a4a2af3a1a689007c2 |
| institution | Directory Open Access Journal |
| issn | 2008-6164 2008-6172 |
| language | English |
| last_indexed | 2024-04-13T23:44:57Z |
| publishDate | 2016-10-01 |
| publisher | Babol University of Medical Sciences |
| record_format | Article |
| series | Caspian Journal of Internal Medicine |
| spelling | doaj.art-facda5b7161146a4a2af3a1a689007c22022-12-22T02:24:23ZengBabol University of Medical SciencesCaspian Journal of Internal Medicine2008-61642008-61722016-10-0174260266The HPLC assay of concentration of azithromycin from two different manufacturers in gingival crevicular fluid (GCF)Mahmoud Khosravi Samani0Khashayar Dehshiri1Sohrab Kazemi2Mohamadreza Shiran3Ali Akbar Moghadamnia4 Department of Periodontology, Babol University of medical sciences, Babol, Iran Department of Periodontology, Babol University of medical sciences, Babol, Iran 2. Neurosciences Research Center, Department of Pharmacology, Babol University of medical sciences, Babol, Iran 3. Department of Pharmacology, Mazandaran University of medical science, Sari, Iran 2. Neurosciences Research Center, Department of Pharmacology, Babol University of medical sciences, Babol, Iran Background: Azithromycin (AZM) is used in periodontal infections. The present study compared gingival crevicular fluid concentration of azithromycin of two pharmaceutical companies through the HPLC method. Methods: Two groups (n=15) of healthy volunteers participated in this study. The first group received an imported azithromycin (ImAZM) tablet (250 mg, PO) and the second group received an azithromycin tablet (250 mg PO) manufactured by an Iranian pharmaceutical company (IrAZM). Intrasulcular paper points (#30) were used in inter-proximal areas of molars and canines to collect gingival crevicular fluid samples at 6, 12, 36, 84 and 156 hours after drug administration. Results: The maximum concentration of AZM in gingival crevicular fluid was detected in each group 36 hour after administration. The concentration levels for the participants receiving ImAZM and IrAZM were 14.38±5.75 and 12.64±3.53 ng/mL, respectively. The pharmacokinetic (PK) modeling data showed half-life of AZM was 107.47 hr & 91.42 hr while the clearance was 113.02 hr &119.0 hr for the group receiving ImAZM and IrAZM, respectively. No significant differences were observed in other PK parameters, areas under the concentration time curves for the groups were almost identical. Conclusion: According to the results, there were no significant differences between the PK parameters of ImAZM and IrAZM products. It may be concluded that different doses of AZM have relatively similar PK parameters among the healthy participants.http://caspjim.com/browse.php?a_code=A-10-108-1&slc_lang=en&sid=1Azithromycin Pharmacokinetics HPLC Gingival crevicular fluid |
| spellingShingle | Mahmoud Khosravi Samani Khashayar Dehshiri Sohrab Kazemi Mohamadreza Shiran Ali Akbar Moghadamnia The HPLC assay of concentration of azithromycin from two different manufacturers in gingival crevicular fluid (GCF) Caspian Journal of Internal Medicine Azithromycin Pharmacokinetics HPLC Gingival crevicular fluid |
| title | The HPLC assay of concentration of azithromycin from two different manufacturers in gingival crevicular fluid (GCF) |
| title_full | The HPLC assay of concentration of azithromycin from two different manufacturers in gingival crevicular fluid (GCF) |
| title_fullStr | The HPLC assay of concentration of azithromycin from two different manufacturers in gingival crevicular fluid (GCF) |
| title_full_unstemmed | The HPLC assay of concentration of azithromycin from two different manufacturers in gingival crevicular fluid (GCF) |
| title_short | The HPLC assay of concentration of azithromycin from two different manufacturers in gingival crevicular fluid (GCF) |
| title_sort | hplc assay of concentration of azithromycin from two different manufacturers in gingival crevicular fluid gcf |
| topic | Azithromycin Pharmacokinetics HPLC Gingival crevicular fluid |
| url | http://caspjim.com/browse.php?a_code=A-10-108-1&slc_lang=en&sid=1 |
| work_keys_str_mv | AT mahmoudkhosravisamani thehplcassayofconcentrationofazithromycinfromtwodifferentmanufacturersingingivalcrevicularfluidgcf AT khashayardehshiri thehplcassayofconcentrationofazithromycinfromtwodifferentmanufacturersingingivalcrevicularfluidgcf AT sohrabkazemi thehplcassayofconcentrationofazithromycinfromtwodifferentmanufacturersingingivalcrevicularfluidgcf AT mohamadrezashiran thehplcassayofconcentrationofazithromycinfromtwodifferentmanufacturersingingivalcrevicularfluidgcf AT aliakbarmoghadamnia thehplcassayofconcentrationofazithromycinfromtwodifferentmanufacturersingingivalcrevicularfluidgcf AT mahmoudkhosravisamani hplcassayofconcentrationofazithromycinfromtwodifferentmanufacturersingingivalcrevicularfluidgcf AT khashayardehshiri hplcassayofconcentrationofazithromycinfromtwodifferentmanufacturersingingivalcrevicularfluidgcf AT sohrabkazemi hplcassayofconcentrationofazithromycinfromtwodifferentmanufacturersingingivalcrevicularfluidgcf AT mohamadrezashiran hplcassayofconcentrationofazithromycinfromtwodifferentmanufacturersingingivalcrevicularfluidgcf AT aliakbarmoghadamnia hplcassayofconcentrationofazithromycinfromtwodifferentmanufacturersingingivalcrevicularfluidgcf |